Intellectual property rights licensing of OBI’s cancer therapies in China has been granted by MOEAIC

1. Date of occurrence of the event: 2021/11/11 2. Company name: OBI Pharma Inc. 3. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office 4. Reciprocal shareholding ratios: Not applicable 5. Cause of occurrence: The Company has received the approval letter from MOEAIC regarding the intellectual property rights licensing of OBI’s cancer […]